Cargando…
Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans
Despite advances in pharmacological treatment, diabetic nephropathy is still the leading cause of end-stage renal disease and an important cause of morbidity and mortality in diabetics. Glycosaminoglycans are long, unbranched mucopolysaccharides that play an important role in establishing a charge-s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284059/ https://www.ncbi.nlm.nih.gov/pubmed/22371788 http://dx.doi.org/10.5114/aoms.2010.14456 |